Dyadic signs European licensing deal to expand non-animal dairy pipeline

The press release says the Nasdaq-listed biotechnology company will add precision-fermented dairy proteins and pursue development, licensing and commercialization revenue as the program moves toward scale-up.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.